Business
BioSpectrum Asia
Biotech Outlook 2026: Advancing AI, Organoids, and Translational Science
The Asia-Pacific biotech sector is entering 2026 with renewed momentum. Investment in the pre-clinical organoid space continues to grow as the industry increasingly explores human-relevant models and aims to reduce reliance on animal testing where scientifically feasible. At the same time, pharmaceutical companies are expanding their focus on next-generation drug modalities – particularly antibody-drug conjugates (ADCs) and targeted protein degradation (TPD) – further strengthening demand for advanced discovery platforms and more predictive research tools.
2 min |
BioSpectrum Asia Dec 2025
BioSpectrum Asia
Africa CDC launches operational research on malaria in Southern Africa
The Africa Centres for Disease Control and Prevention (Africa CDC) has launched operational research on malaria in Lesotho, Namibia and Zimbabwe, supported by a $150,000 grant from the World Bank.
1 min |
BioSpectrum Asia Dec 2025
BioSpectrum Asia
Australia to establish independent Centre for Disease Control
The government of Australia has passed legislation to deliver on its commitment to establish an independent Australian Centre for Disease Control (CDC).
1 min |
BioSpectrum Asia Dec 2025
BioSpectrum Asia
Free Trade Agreements: Catalysts for Asia's Pharma Growth and Global Access
Asia has emerged as a pivotal hub in the global pharmaceutical landscape. With countries like India, China, South Korea, Japan, and Singapore driving significant production, research, and innovation, the region accounts for an increasingly large share of global pharmaceutical output. Free Trade Agreements (FTAs) are reshaping this scenario, serving as strategic instruments to reduce trade barriers, streamline regulatory frameworks, and foster regional and global collaboration. By lowering tariffs, simplifying customs procedures, and providing stronger intellectual property protections, FTAs enable pharmaceutical companies to access new markets more efficiently, scale production, and offer affordable medicines worldwide.
4 min |
BioSpectrum Asia Dec 2025
BioSpectrum Asia
EirGenix partners with Sandoz for breast cancer biosimilar in $152 M deal
Taiwan-based EirGenix Inc. has entered into a second global exclusive licensing agreement with international biosimilar leader Sandoz AG for the commercialisation of its independently developed breast cancer biosimilar, EG1206A (Pertuzumab Biosimilar to Roche Perjeta), covering all territories except Taiwan, Mainland China, Macau, South Korea, Mongolia, Brunei, Cambodia, Indonesia, Laos, Myanmar, the Philippines, and Japan.
1 min |
BioSpectrum Asia Dec 2025
BioSpectrum Asia
Life Sciences Trends 2026: From Regulatory Agility, AI and Investments to Digital Health Transformation
As the curtains close on 2025, it's time to reflect on how the year unfolded. BioSpectrum encapsulates some of the key trends for 2026, starting with the reigning behemoth, China. To understand what lies ahead for the life-sciences sector, BioSpectrum Asia spoke with analysts from across its major market segments. Their insights reveal the following key predictions spanning pharma, biotech, medtech, healthcare, digital health, and manufacturing that are expected to define the industry in the year to come. Let's dive deeper.
10+ min |
BioSpectrum Asia Dec 2025
BioSpectrum Asia
New WHO report urges bold steps for equitable access to novel TB vaccines
A new WHO report calls for bold financing and access strategies to ensure novel tuberculosis (TB) vaccines reach adolescents and adults in high-burden countries.
1 min |
BioSpectrum Asia Dec 2025
BioSpectrum Asia
Meiji to establish Singapore subsidiary to expand biz in ASEAN region
Japan's Meiji Seika Pharma has decided to establish a local subsidiary in Singapore to strengthen its presence and expand its business in the ASEAN region.
1 min |
BioSpectrum Asia Dec 2025
BioSpectrum Asia
WHO launches global guidelines on diabetes during pregnancy
The World Health Organization (WHO) has released its first global guidelines for the management of diabetes during pregnancy, a condition affecting about one in six pregnancies - or 21 million women annually.
1 min |
BioSpectrum Asia Dec 2025
BioSpectrum Asia
Roche inks nearly $1 B deal with Qyuns Therapeutics
China's Qyuns Therapeutics has entered into a global exclusive collaboration and license agreement with F. Hoffmann-La Roche Ltd, pursuant to which the company grants Roche the global exclusive right to develop, manufacture, and commercialise QX031N.
1 min |
BioSpectrum Asia Dec 2025
BioSpectrum Asia
Helex raises $3.5 M to advance targeted gene therapies for kidney diseases
Helex, a US and India based therapeutics startup developing a new class of targeted medicines for genetic kidney diseases, has announced its oversubscribed $3.5 million Seed round, led by pi Ventures.
1 min |
BioSpectrum Asia Dec 2025
BioSpectrum Asia
Brazil pledges $72 M in support of Gavi's global immunisation efforts
Brazil has announced a landmark pledge of $72 million to Gavi, the Vaccine Alliance for the organisation's 2026-2030 strategic period.
1 min |
BioSpectrum Asia Dec 2025
BioSpectrum Asia
Mölnlycke opens first wound care manufacturing site in China
Mölnlycke Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, recently celebrated the commencement of its new wound care manufacturing site in Changshu, China.
1 min |
BioSpectrum Asia Dec 2025
BioSpectrum Asia
Dubai Medical University launches first department of integrative medicine
Dubai Medical University has announced the establishment of the Department of Integrative Medicine under the College of Pharmacy.
1 min |
BioSpectrum Asia Dec 2025
BioSpectrum Asia
Kotak Alts invests Rs 40 Cr in Mediversal Healthcare
Kotak Alternate Asset Managers Limited (Kotak Alts), through its Kotak Life Science Fund I, which invests in early to growth-stage life sciences and healthcare businesses in India, has made an investment of Rs 40 crore in Mediversal Healthcare.
1 min |
BioSpectrum Asia Dec 2025
BioSpectrum Asia
Waters launches charge detection mass spectrometry technology
US-based Waters Corporation has unveiled the Waters Xevo Charge Detection Mass Spectrometer (CDMS), delivering unmatched measurement and characterisation for the broadest range of mega-mass biomolecules central to next-generation therapeutics and structural biology.
1 min |
BioSpectrum Asia Nov 2025
BioSpectrum Asia
Chulalongkorn University launches Thailand's first master's programme in Nurse Anesthesia
The Faculty of Nursing, Chulalongkorn University, has officially launched the \"Master of Nursing Science Programme in Nurse Anesthesia\" - the first of its kind in Thailand.
1 min |
BioSpectrum Asia Nov 2025
BioSpectrum Asia
WHO strengthens coordination for NTD programmes and supply chain delivery
The World Health Organization (WHO), together with health ministries, pharmaceutical donours, implementing partners and technical support platforms, is strengthening coordination for neglected tropical disease (NTD) programmes and supply chain delivery, through three major back-to-back meetings in Geneva.
1 min |
BioSpectrum Asia Nov 2025
BioSpectrum Asia
All-in-one coronavirus vaccines to save millions in future pandemics
A new study reveals that vaccines designed to protect against a wide range of coronaviruses could dramatically reduce deaths and economic disruption and limit the need for lockdowns in the event of another global coronavirus pandemic.
1 min |
BioSpectrum Asia Nov 2025
BioSpectrum Asia
NTU in Singapore introduces Master of Science course in Chinese Medicine
From 2026, Nanyang Technological University (NTU) in Singapore will start offering a Master of Science in Chinese Medicine to develop highly skilled postgraduates with advanced expertise in both the theoretical foundations and practical applications of Chinese medicine.
1 min |
BioSpectrum Asia Nov 2025
BioSpectrum Asia
ProSpecBio launches Activin-A recombinant protein for brain injury research
Israel-based ProSpecBio, an evolving biotech company dedicated to providing highly purified proteins to the global research community, has announced the launch of its latest product: CHO cell-derived recombinant Activin-A, now available for immediate delivery worldwide.
1 min |
BioSpectrum Asia Nov 2025
BioSpectrum Asia
PAHO publishes guide for designing AI instructions in public health
The Pan American Health Organization (PAHO) has launched a new guide providing practical advice on how to create Artificial Intelligence (AI) prompts that generate reliable, relevant, and culturally appropriate content across diverse contexts.
1 min |
BioSpectrum Asia Nov 2025
BioSpectrum Asia
Prerna launches India's first MicroRNA based blood test for breast cancer screening
Precision RNA Biotech (Prerna), a healthcare startup from Hyderabad, India has announced the launch of Cantel, India's first microRNA-based blood test for breast cancer screening.
1 min |
BioSpectrum Asia Nov 2025
BioSpectrum Asia
Poly Medicure announces acquisition of Citieffe Group for Rs 324 Cr
India-based medtech firm Poly Medicure has announced signing of a definitive agreement to acquire 100 per cent stake in Medistream SA (Group) consisting of Citieffe SRL and its step-down subsidiaries in USA & Mexico, at an Enterprise Value of Rs 324 crore (EUR 31 million).
1 min |
BioSpectrum Asia Nov 2025
BioSpectrum Asia
Sumitomo, Novo Nordisk to co-promote obesity drug Wegovy in Japan
Sumitomo Pharma and Novo Nordisk Pharma have entered into a co-promotion agreement in Japan for Wegovy Subcutaneous Injection, a once-weekly subcutaneous injection formulation of GLP-1 receptor agonist indicated for the treatment of obesity disease.
1 min |
BioSpectrum Asia Nov 2025
BioSpectrum Asia
Cell Therapies partners with Teijin to expand access to advanced CGT in APAC
Australia-based Cell Therapies and Japan's Teijin have signed a Memorandum of Understanding (MoU) to strengthen regional infrastructure for cell and gene therapies (CGT), leveraging advanced GMP capabilities and cross-border collaboration to accelerate development and improve patient access across Japan and the wider Asia Pacific (APAC) region.
1 min |
BioSpectrum Asia Nov 2025
BioSpectrum Asia
Singapore boosts medtech regulatory support and market access
The Health Sciences Authority (HSA) and the Singapore Manufacturing Federation Medical Technology Industry Group (SMF MTIG) are pioneering a comprehensive support ecosystem for Singapore's MedTech industry through their strategic partnership, combining the SME Centre@SMF's services with HSA's Health Products Regulation Group (HPRG) Innovation Office's technical regulatory expertise.
1 min |
BioSpectrum Asia Nov 2025
BioSpectrum Asia
US FDA authorises marketing of first eyeglass lenses to slow progression of paediatric myopia
The US Food and Drug Administration (FDA) has authorised marketing of the Essilor Stellest eyeglass lenses to correct myopia, commonly referred to as nearsightedness, with or without astigmatism and to slow the progression of the disease in children 6 to 12 years old at the initiation of treatment.
1 min |
BioSpectrum Asia Nov 2025
BioSpectrum Asia
Korea designs bioadhesive sponge offering new way to stop internal bleeding
Uncontrolled bleeding during surgery remains one of the deadliest medical emergencies.
1 min |
BioSpectrum Asia Nov 2025
BioSpectrum Asia
K-Bio Lab Hub inks MoU with Australia's Monash University
Australia’s biotech capital, Melbourne, has further strengthened its research and development capabilities through a newly formed Memorandum of Understanding (MoU) between Monash University and K-Bio Lab Hub — South Korea’s government-backed biotech incubator.
1 min |